Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
JIB

Cardiac Tissue Generated from Human Embryonic Stem Cells Displays Aspects of Both Mature and Immature Heart Muscle

By BiotechDaily International staff writers
Posted on 19 Feb 2014
An in vitro model system based on cardiac tissue generated from human embryonic stem cells displayed some of the physiological responses known to occur in the natural adult human heart while other responses more closely mimicked the immature or newborn human heart.

Cardiac experimental biology and translational research would benefit from an in vitro surrogate for human heart muscle. To this end, investigators at the Icahn School of Medicine at Mount Sinai (New York, NY, USA) studied the structural and functional properties and interventional responses of human engineered cardiac tissues (hECTs) compared to normal human heart tissues.

After transforming human embryonic stem cells into hECTs the investigators mixed them with collagen and cultured them on force-sensing elastomer devices that exercised the tissue and permitted measurement of its contractile force throughout the culture process.

Results published in the February 2014 issue of the FASEB Journal revealed that within seven to 10 days, the induced cardiac cells self-assembled into a three-dimensional strip of tissue that beat spontaneously in a manner similar to natural heart muscle. The cultured strips of tissue, which were able to survive for at least a month, displayed contractile activity in a rhythmic pattern of 70 beats per minute on average.

The heart tissue model responded to electrical and chemical stimulation and was able to incorporate new genetic information delivered by adenovirus gene therapy. During functional analysis, the hECTs displayed some responses known to occur in the natural adult human heart, while other responses more closely mimicked the immature or newborn human heart.

"We hope that our human engineered cardiac tissues will serve as a platform for developing reliable models of the human heart for routine laboratory use," said senior author Dr. Kevin D. Costa, associate professor of cardiology and at the Icahn School of Medicine at Mount Sinai. "This could help accelerate and revolutionize cardiology research by improving the ability to efficiently discover, design, develop, and deliver new therapies for the treatment of heart disease, and by providing more efficient screening tools to identify and prevent cardiac side effects, ultimately leading to safer and more effective treatments for patients suffering from heart disease."

Related Links:

Icahn School of Medicine at Mount Sinai



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The five stages of biofilm development: (1) Initial attachment, (2) Irreversible attachment, (3) Maturation I, (4) Maturation II, and (5) Dispersion. Each stage of development in the diagram is paired with a photomicrograph of a developing P. aeruginosa biofilm. All photomicrographs are shown to same scale (Photo courtesy of Wikimedia Commons).

Ionic Liquids Disperse Bacterial Biofilms and Increase Antibiotic Susceptibility

The ionic liquid choline-geranate was shown to effectively eliminate the protective biofilm generated by bacteria such as Salmonella enterica and Pseudomonas aeruginosa and to significantly increase the... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Lab Technologies

view channel

Important Immune Cell Regulators’ Response Identified

A new strategy could help accelerate laboratory research and the development of potential therapeutics, including vaccines. The technology may also be used to identify the genes that underlie tumor cell development. There are approximately 40,000 genes in each of the body’s cells, but functions for only approximately... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.